ACE2 reduces cytokine release and inhibits signaling pathways of tissue fibrosis in experimental models of obesity (Rodrigues Prestes et al., 2017) and its deficiency in epicardial adipose tissue worsens inflammation and cardiac dysfunction in response to diet-induced obesity (Patel et al., 2016). The gene discussed is ACE2; the disease is obesity disorder.